Benjamin Houlton reappointed CALS dean

The Cornell Board of Trustees’ Executive Committee voted Oct. 14 to approve a new five-year term, effective July 1, 2025.

A fully automated AI-based system can assess IVF embryo quality

A new system can accurately assess the chromosomal status of in vitro-fertilized embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.

How melanoma cells escape oxidative stress to metastasize

Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread. 

University celebrates top faculty for outstanding teaching, mentoring

Eleven teaching faculty from across the university have been awarded Cornell’s highest honors for graduate and undergraduate teaching, Interim President Michael I. Kotlikoff announced Oct. 22.

CCE appoints human nutrition, food safety & obesity prevention lead

Angela Odoms-Young is the critical issue lead for extension programming in the areas of human nutrition, food safety and security and obesity prevention, effective October 1, 2024. The appointment reflects CCE's dedication to leveraging campus resources and CCE educators and collaborators across the state, to ensure that needs are met and key metrics and benchmarks for educational work are identified. 

Around Cornell

Silvia Formenti, Massimo Loda elected to National Academy of Medicine

Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.

Gift names the Joan Klein Jacobs Center for Precision Nutrition and Health

A gift totaling $25 million from Irwin M. Jacobs ’54, BEE ’56 and the Jacobs family includes a new $15 million commitment, adding to a $10 million commitment in 2023 that helped establish the center.

FDA commissioner in talk urges Cornell community to focus on US health

The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.

Biomarker may predict immunotherapy response in liver cancer

A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.